SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-22-000009
Filing Date
2022-08-08
Accepted
2022-08-08 16:27:01
Documents
109
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20220630.htm   iXBRL 10-Q 2088425
2 EX-31.1 pgen-20220630xexx311.htm EX-31.1 10479
3 EX-31.2 pgen-20220630xexx312.htm EX-31.2 10142
4 EX-32.1 pgen-20220630xexx321.htm EX-32.1 5904
5 EX-32.2 pgen-20220630xexx322.htm EX-32.2 5981
  Complete submission text file 0001356090-22-000009.txt   10545929

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20220630.xsd EX-101.SCH 69799
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20220630_cal.xml EX-101.CAL 117954
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20220630_def.xml EX-101.DEF 457382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20220630_lab.xml EX-101.LAB 834359
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20220630_pre.xml EX-101.PRE 647284
103 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20220630_htm.xml XML 1819354
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 221144780
SIC: 2834 Pharmaceutical Preparations